Literature DB >> 16362382

The management of infections due to drug-resistant gram-positive bacteria.

R C Moellering1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16362382     DOI: 10.1007/s10096-005-0062-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

Review 1.  Control of methicillin-resistant Staphylococcus aureus in the UK.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 2.  Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 3.  Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.

Authors:  I Klare; C Konstabel; S Mueller-Bertling; G Werner; B Strommenger; C Kettlitz; S Borgmann; B Schulte; D Jonas; A Serr; A M Fahr; U Eigner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 4.  Antibiotics and gastrointestinal colonization by vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 5.  Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection.

Authors:  M H Kollef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 6.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

7.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

  7 in total
  3 in total

1.  Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.

Authors:  Jae Il Yoo; Jung Wook Kim; Gi Su Kang; Hwa Su Kim; Jung Sik Yoo; Yeong Seon Lee
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

2.  Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.

Authors:  Yuki Katayama; Hiroko Murakami-Kuroda; Longzhu Cui; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.

Authors:  Yubing Wang; Xiaoli Li; Libo Jiang; Wentao Han; Xiangming Xie; Yi Jin; Xiaoqing He; Rongling Wu
Journal:  Front Microbiol       Date:  2017-01-10       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.